HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $451,000 | -25.9% | 10,839 | -53.2% | 0.01% | -33.3% |
| Q3 2020 | $609,000 | +33.6% | 23,159 | -10.0% | 0.02% | +114.3% |
| Q4 2019 | $456,000 | +204.0% | 25,742 | +150.5% | 0.01% | +40.0% |
| Q4 2018 | $150,000 | -83.1% | 10,277 | -77.2% | 0.01% | -64.3% |
| Q1 2018 | $885,000 | +61.2% | 45,130 | +5.3% | 0.01% | +133.3% |
| Q2 2017 | $549,000 | +104.9% | 42,849 | +107.1% | 0.01% | +100.0% |
| Q1 2017 | $268,000 | +45.7% | 20,687 | +51.0% | 0.00% | -25.0% |
| Q3 2015 | $184,000 | +34.3% | 13,700 | -3.7% | 0.00% | -33.3% |
| Q4 2014 | $137,000 | – | 14,226 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |